Lilly reports the combo changed 482 proteins versus 140 with Taltz alone by week 36, in a trial of 274 adults with psoriasis and obesity.
Recap by typeshit. Full story at PR Newswire.
The digital health doctor shares a take on GLP-1 therapy paired with lifestyle change and digital programs, calling the finding unsurprising.
Novo Nordisk shared the figure from a post-trial analysis of its next-generation experimental drug, with results broken out for women.
Patients moved off weekly Wegovy injections onto a daily pill, and Men's Journal reports one group's weight outcomes stood out from the rest.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Bloomberg looks at people using untested peptides in hopes of thinking faster, getting an edge or holding off aging.
Emory's Angela Haynes-Ferere, who takes a GLP-1 herself, and Cedars-Sinai's Amanda Velazquez explain why weight loss stalls and why stopping the drug isn't the answer.
Loading…